Recent research focusing on Tirzepatide at a dosage of 20mg is shedding new light on its potential benefits. Initial findings suggest that this higher dosage may enhance the drug's ability to manage blood sugar, potentially offering improved outcomes for individuals with insulin resistance. Further investigation is underway to fully evaluate the lo